Bristol Myers Squibb to Host Virtual Investor Event to Discuss Results from Phase 3 True North Trial Evaluating Zeposia® in Ulcerative Colitis at UEG Week 2020 Biotech Investing
Perimeter Medical Imaging AI Announces Further Update Regarding Second Quarter Financial Statements Medical Device Investing
Gilead Sciences Update on Supply and Distribution of Veklury® in the United States Biotech Investing
Medtronic Resolute Onyx Drug Eluting Stent First to Receive One-Month DAPT Labeling in the U.S. with Expanded Indication for High Bleeding Risk Patients Medical Device Investing
Nielsen's BASES Names LUMIFY® Eye Drops To 2020 U.S. BASES Top 25 Breakthrough Innovations List Medical Device Investing
Merck to Present New Data from the Company's Diverse HIV Portfolio and Pipeline at HIV Glasgow 2020 Pharmaceutical Investing
Pfizer Receives FDA Fast Track Designation for Duchenne Muscular Dystrophy Investigational Gene Therapy Pharmaceutical Investing
Merck to Hold Third-Quarter 2020 Sales and Earnings Conference Call on October 27 Pharmaceutical Investing
Seegnal Expands Deployment of Seegnal's Prescription Intelligence Platform at Tel Aviv Sourasky Medical Center, a Leading Israeli Public Medical Center and Global Referral Center
